2020
DOI: 10.1016/j.det.2019.08.013
|View full text |Cite
|
Sign up to set email alerts
|

Phototherapy for Cutaneous T-Cell Lymphoma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
10
0

Year Published

2020
2020
2025
2025

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 14 publications
(10 citation statements)
references
References 48 publications
0
10
0
Order By: Relevance
“…In the early stages of cutaneous T cell lymphoma, besides topical steroids and nitrogen mustard (28), phototherapy can also be considered, PUVA and NB-UVB being first-line treatments. PUVA phototherapy seems to be associated with much more favorable results (29). A study conducted by Ahmad et al (30) showed the effectiveness of both NB-UVB phototherapy and PUVA phototherapy, registering complete remissions especially in the early stages (IA, IB) of cutaneous T cell lymphoma in 50 and 64% of patients, respectively (30).…”
Section: Indications For Phototherapy In Dermatologymentioning
confidence: 99%
“…In the early stages of cutaneous T cell lymphoma, besides topical steroids and nitrogen mustard (28), phototherapy can also be considered, PUVA and NB-UVB being first-line treatments. PUVA phototherapy seems to be associated with much more favorable results (29). A study conducted by Ahmad et al (30) showed the effectiveness of both NB-UVB phototherapy and PUVA phototherapy, registering complete remissions especially in the early stages (IA, IB) of cutaneous T cell lymphoma in 50 and 64% of patients, respectively (30).…”
Section: Indications For Phototherapy In Dermatologymentioning
confidence: 99%
“…The classic feature of MF is erythematous patches which eventually developing into plaques, tumors, and erythroderma. 56 Another type is Sezary syndrome (SS), manifested as erythroderma and the presence of circulating atypical T cells with or without lymphadenopathy. 57 MF is effectively treated using phototherapy.…”
Section: Cutaneous T Cell Lymphoma (Loe Ii)mentioning
confidence: 99%
“…This is expected to bring to the market several treatments at a lower risk, reduced cost, and less development time when compared to conventional drug development programs ( 202 204 ). One of the most interesting classes of molecules are psoralens, extensively studied as molecules to be employed in PUVA (Psoralen and Ultraviolet A)-therapy, a treatment extensively used in a variety of pathological conditions, including eczema, psoriasis, graft-vs.-host disease, vitiligo, mycosis fungoides, large-plaque parapsoriasis, and cutaneous T-cell lymphoma ( 205 ). It was in a study that found that 5-methoxypsoralen reduces P. aeruginosa -dependent IL-8 transcription in bronchial epithelial cell lines ( 206 ).…”
Section: Targeting Neutrophil Chemotaxis In Cf: Novel Molecules and Dmentioning
confidence: 99%